Respirion Pharmaceuticals, a spin-off of the Telethon Kids Institute, will receive an investment of over $20 million from the Australian government’s Medical Research Commercialization Fund (MRCF)  as well as the US Cystic Fibrosis Foundation. The spin-off company has...